ArticleThe Journal of international medical research2023

Late-stage esophageal neuroendocrine carcinoma in a patient treated with tislelizumab combined with anlotinib: a case report.

Yanqi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.